Patent details

EP4025235 Title: OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITIS

Basic Information

Publication number:
EP4025235
PCT Application Number:
EP2020074884
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207646902
PCT Publication Number:
WO2021044045
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITIS
French Title of Invention:
COMPOSITION OPHTALMIQUE POUR LE TRAITEMENT DE L'UVÉITE
German Title of Invention:
OPHTHALMISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON UVEITIS
SPC Number:

Dates

Filing date:
05/09/2020
Grant date:
25/02/2026
EP Publication Date:
13/07/2022
PCT Publication Date:
11/03/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/02/2026
EP B1 Publication Date:
25/02/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/09/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/02/2026
 
 

Name:
Novaliq GmbH
Address:
Im Neuenheimer Feld 515, 69120 Heidelberg, Germany (DE)

Inventor

1

Name:
LÖSCHER, Frank
Address:
Germany (DE)

2

Name:
BEIER, Markus
Address:
Germany (DE)

3

Name:
HAISSER, Jörg
Address:
Germany (DE)

4

Name:
LEO, Chiara Silvana
Address:
Germany (DE)

Priority

Priority Number:
19195793
Priority Date:
06/09/2019
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61P 31/02; A61K 9/00; A61K 9/08; A61K 38/13; A61K 47/06; A61K 47/10; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
202609
Publication date:
25/02/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages